Your browser doesn't support javascript.
loading
Assessment of quality of life in epilepsy patients receiving anti-epileptic drugs in a tertiary care teaching hospital.
Pimpalkhute, Sonali A; Bajait, Chaitali S; Dakhale, Ganesh N; Sontakke, Smita D; Jaiswal, Kavita M; Kinge, Parag.
Afiliación
  • Pimpalkhute SA; Department of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.
  • Bajait CS; Department of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.
  • Dakhale GN; Department of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.
  • Sontakke SD; Department of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.
  • Jaiswal KM; Department of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.
  • Kinge P; Department of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.
Indian J Pharmacol ; 47(5): 551-4, 2015.
Article en En | MEDLINE | ID: mdl-26600647
OBJECTIVES: Health-related quality of life (QOL) is an important outcome in epilepsy treatment. Very few studies have been carried out on the quality of life in epilepsy (QOLIE-31) in India. The present study aimed to determine the level of health-related QOLIE-31 in patients of epilepsy. MATERIALS AND METHODS: This was a cross-sectional, questionnaire-based study conducted in a tertiary care teaching hospital. Respondents were adults aged at least 18-year-old with a diagnosis of epilepsy. QOLIE-31 was used for collecting data on health-related QOL. The unpaired t-test or one-way analysis of variance was used to compare means of QOL scores between groups. RESULTS: Totally, 60 patients of epilepsy were included in the study. The mean (standard deviation) total score of QOLIE-31 was 64.61. A score of cognitive and medication effect were significantly better in carbamazepine group as compared to valproate group. CONCLUSIONS: Patients on monotherapy had a better QOL as compared to patients receiving polytherapy.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Calidad de Vida / Epilepsia / Anticonvulsivantes Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Indian J Pharmacol Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Calidad de Vida / Epilepsia / Anticonvulsivantes Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Indian J Pharmacol Año: 2015 Tipo del documento: Article